RVL Pharmaceuticals plc Operating Income
RVL Pharmaceuticals plc reported Operating Income of -$22.02 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-08-14
- RVL Pharmaceuticals plc operating income (loss) for the quarter ending 2023-06-30 was -$22.02M.
- RVL Pharmaceuticals plc operating income (loss) for the quarter ending 2023-03-31 was -$10.29M.
- RVL Pharmaceuticals plc operating income (loss) for the quarter ending 2022-12-31 was -$24.55M.
- RVL Pharmaceuticals plc operating income (loss) for the quarter ending 2022-09-30 was -$13.92M.
- RVL Pharmaceuticals plc operating income (loss) for fiscal 2022 was -$58.99M.
- RVL Pharmaceuticals plc operating income (loss) for fiscal 2021 was -$82.75M.
- RVL Pharmaceuticals plc operating income (loss) for fiscal 2020 was -$90.65M.
- RVL Pharmaceuticals plc operating income (loss) for fiscal 2018 was -$98.54M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$22.02M 10-Q · filed 2023-08-14 | -$32.31M 10-Q · filed 2023-08-14 | -$56.86M derived: sum of 3 quarters · filed 2023-08-14 | -$70.78M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | -$10.29M 10-Q · filed 2023-05-11 | -$34.84M derived: sum of 2 quarters · filed 2023-05-11 | -$48.76M derived: sum of 3 quarters · filed 2023-05-11 | -$63.88M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | -$24.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$38.47M derived: sum of 2 quarters · filed 2023-03-20 | -$53.59M derived: sum of 3 quarters · filed 2023-08-14 | -$58.99M 10-K · filed 2023-03-20 | ||||
| 2022-09-30 | -$13.92M 10-Q · filed 2022-11-10 | -$29.05M derived: sum of 2 quarters · filed 2023-08-14 | -$34.44M 10-Q · filed 2022-11-10 | -$57.50M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | -$15.12M 10-Q · filed 2023-08-14 | -$20.52M 10-Q · filed 2023-08-14 | -$43.58M derived: sum of 3 quarters · filed 2023-08-14 | -$68.75M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$5.40M 10-Q · filed 2023-05-11 | -$28.45M derived: sum of 2 quarters · filed 2023-05-11 | -$53.62M derived: sum of 3 quarters · filed 2023-05-11 | -$73.80M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$23.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$48.23M derived: sum of 2 quarters · filed 2023-03-20 | -$68.40M derived: sum of 3 quarters · filed 2023-03-20 | -$82.75M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$25.17M 10-Q · filed 2022-11-10 | -$45.35M derived: sum of 2 quarters · filed 2022-11-10 | -$59.70M 10-Q · filed 2022-11-10 | -$110.80M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$20.18M 10-Q · filed 2022-08-11 | -$33.44M 10-Q · filed 2022-08-11 | -$33.45M 10-Q · filed 2021-08-16 | -$85.64M derived: sum of 3 quarters · filed 2022-08-11 | -$84.21M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | -$13.26M 10-Q · filed 2022-05-12 | -$6.21M 10-Q · filed 2021-05-13 | -$65.46M derived: sum of 2 quarters · filed 2022-05-12 | -$64.03M derived: sum of 3 quarters · filed 2022-05-12 | -$81.35M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | -$52.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$50.77M derived: sum of 2 quarters · filed 2022-03-30 | -$68.08M derived: sum of 3 quarters · filed 2022-03-30 | -$90.65M 10-K · filed 2022-03-30 | -$70.44M 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $1.43M 10-Q · filed 2021-11-15 | -$6.35M 10-Q · filed 2020-11-10 | -$15.89M derived: sum of 2 quarters · filed 2021-11-15 | -$38.46M 10-Q · filed 2021-11-15 | -$13.57M 10-Q · filed 2020-11-10 | $115.80M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | -$17.32M 10-Q · filed 2021-08-16 | -$8.41M 10-Q · filed 2020-08-11 | -$39.79M 10-Q · filed 2021-08-16 | -$7.21M 10-Q · filed 2020-08-11 | $114.37M derived: sum of 3 quarters · filed 2021-09-08 | -$8.63M derived: sum of 4 quarters · filed 2021-09-08 | ||
| 2020-03-31 | $1.20M 10-Q · filed 2021-05-13 | $131.69M derived: sum of 2 quarters · filed 2021-09-08 | $8.69M derived: sum of 3 quarters · filed 2021-09-08 | -$123.06M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2019-12-31 | $130.49M derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | $7.49M derived: sum of 2 quarters · filed 2021-09-08 | -$124.26M derived: sum of 3 quarters · filed 2021-09-08 | -$127.76M 8-K · filed 2021-09-08 | -$280.69M 10-K · filed 2020-03-19 | |||
| 2019-09-30 | -$123.00M 10-Q · filed 2020-11-10 | -$123.00M 10-Q · filed 2019-11-14 | -$254.75M derived: sum of 2 quarters · filed 2020-11-10 | -$258.25M 10-Q · filed 2020-11-10 | -$258.25M 10-Q · filed 2019-11-14 | -$365.73M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | -$131.75M 10-Q · filed 2020-08-11 | -$131.75M 10-Q · filed 2019-08-08 | -$135.25M 10-Q · filed 2020-08-11 | -$135.25M 10-Q · filed 2019-08-08 | -$242.73M derived: sum of 3 quarters · filed 2020-08-11 | -$245.33M derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | -$3.50M 10-Q · filed 2020-05-12 | -$3.50M 10-Q · filed 2019-05-09 | -$110.98M derived: sum of 2 quarters · filed 2020-05-12 | -$113.58M derived: sum of 3 quarters · filed 2020-05-12 | -$100.94M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | -$107.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$110.08M derived: sum of 2 quarters · filed 2020-03-19 | -$97.44M derived: sum of 3 quarters · filed 2020-03-19 | -$98.54M 10-K · filed 2020-03-19 | -$98.54M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | -$2.60M 10-Q · filed 2019-11-14 | -$2.60M 10-Q · filed 2018-11-08 | $10.04M derived: sum of 2 quarters · filed 2019-11-14 | $8.94M 10-Q · filed 2019-11-14 | -$3.24M derived: sum of 4 quarters · filed 2019-12-20 | |||
| 2018-06-30 | $12.64M 10-Q · filed 2019-08-08 | $11.54M 10-Q · filed 2019-08-08 | -$643.39K derived: sum of 3 quarters · filed 2019-12-20 | -$18.86M derived: sum of 4 quarters · filed 2019-12-20 | ||||
| 2018-03-31 | -$1.10M 10-Q · filed 2019-05-09 | -$13.28M derived: sum of 2 quarters · filed 2019-12-20 | -$31.50M derived: sum of 3 quarters · filed 2019-12-20 | |||||
| 2017-12-31 | -$12.19M derived: 8-K 12 month − 10-Q 9 month · filed 2019-12-20 | -$30.41M derived: sum of 2 quarters · filed 2019-12-20 | -$52.07M 8-K · filed 2019-12-20 | |||||
| 2017-09-30 | -$18.22M 10-Q · filed 2018-11-08 | -$39.88M 10-Q · filed 2018-11-08 |